Aurobindo Pharma Receives FDA Approval to Manufacture Generic Narcolepsy Drug

by Kathy Jones on  September 29, 2012 at 2:38 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Indian drug maker Aurobindo Pharma revealed that it has received approval from the US Food and Drug Administration to manufacture modafinil tablets in the US.
 Aurobindo Pharma Receives FDA Approval to Manufacture Generic Narcolepsy Drug
Aurobindo Pharma Receives FDA Approval to Manufacture Generic Narcolepsy Drug

The company said that it has received approval to manufacture the tablets in 100 mg and 200 mg strengths and added that the tablets were approved out of its Unit-VII formulations facility in Hyderabad.

Modafinil tablets are generic versions of Provigil tablets manufactured by Cephalon Inc and are used in treating narcolepsy, shift work sleep disorders and excessive daytime sleepiness associated with obstructive sleep apnea. According to figures from IMS Health, modafinil tablets accounted for more than $1.2 billion in sales for the last 12 months ending March 2012.


Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Parasomnias - Part II Sleep Disorders in Children REM Behavior Disorder Sleep Disorders: A Prelude Narcolepsy Hypersomnia Signature Drug Toxicity Sleep Paralysis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive